nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0339	0.0482	CcSEcCtD
Eszopiclone—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0266	CcSEcCtD
Eszopiclone—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0254	CcSEcCtD
Eszopiclone—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0234	CcSEcCtD
Eszopiclone—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0221	CcSEcCtD
Eszopiclone—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0212	CcSEcCtD
Eszopiclone—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0204	CcSEcCtD
Eszopiclone—Gout—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0196	CcSEcCtD
Eszopiclone—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0194	CcSEcCtD
Eszopiclone—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0187	CcSEcCtD
Eszopiclone—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0152	CcSEcCtD
Eszopiclone—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0151	CcSEcCtD
Eszopiclone—Injury—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0145	CcSEcCtD
Eszopiclone—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0144	CcSEcCtD
Eszopiclone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00997	0.0142	CcSEcCtD
Eszopiclone—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00984	0.014	CcSEcCtD
Eszopiclone—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00963	0.0137	CcSEcCtD
Eszopiclone—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00929	0.0132	CcSEcCtD
Eszopiclone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00922	0.0131	CcSEcCtD
Eszopiclone—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00922	0.0131	CcSEcCtD
Eszopiclone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00904	0.0129	CcSEcCtD
Eszopiclone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0126	CcSEcCtD
Eszopiclone—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0088	0.0125	CcSEcCtD
Eszopiclone—GABRG3—Ion channel transport—CLCN5—nephrolithiasis	0.0087	0.0293	CbGpPWpGaD
Eszopiclone—GABRG3—Ion channel transport—CLCN4—nephrolithiasis	0.0087	0.0293	CbGpPWpGaD
Eszopiclone—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00858	0.0122	CcSEcCtD
Eszopiclone—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00852	0.0121	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00843	0.012	CcSEcCtD
Eszopiclone—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00843	0.012	CcSEcCtD
Eszopiclone—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00829	0.0118	CcSEcCtD
Eszopiclone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00826	0.0117	CcSEcCtD
Eszopiclone—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00809	0.0115	CcSEcCtD
Eszopiclone—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00809	0.0115	CcSEcCtD
Eszopiclone—GABRA4—Ion channel transport—CLCN5—nephrolithiasis	0.00801	0.027	CbGpPWpGaD
Eszopiclone—GABRA4—Ion channel transport—CLCN4—nephrolithiasis	0.00801	0.027	CbGpPWpGaD
Eszopiclone—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00757	0.0108	CcSEcCtD
Eszopiclone—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00748	0.0106	CcSEcCtD
Eszopiclone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00745	0.0106	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00739	0.0105	CcSEcCtD
Eszopiclone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00737	0.0105	CcSEcCtD
Eszopiclone—GABRB2—Ion channel transport—CLCN5—nephrolithiasis	0.00732	0.0247	CbGpPWpGaD
Eszopiclone—GABRB2—Ion channel transport—CLCN4—nephrolithiasis	0.00732	0.0247	CbGpPWpGaD
Eszopiclone—GABRA5—Ion channel transport—CLCN5—nephrolithiasis	0.00711	0.024	CbGpPWpGaD
Eszopiclone—GABRA5—Ion channel transport—CLCN4—nephrolithiasis	0.00711	0.024	CbGpPWpGaD
Eszopiclone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00707	0.0101	CcSEcCtD
Eszopiclone—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00701	0.00997	CcSEcCtD
Eszopiclone—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00701	0.00997	CcSEcCtD
Eszopiclone—GABRA3—Ion channel transport—CLCN5—nephrolithiasis	0.00699	0.0236	CbGpPWpGaD
Eszopiclone—GABRA3—Ion channel transport—CLCN4—nephrolithiasis	0.00699	0.0236	CbGpPWpGaD
Eszopiclone—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00692	0.00983	CcSEcCtD
Eszopiclone—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00688	0.00978	CcSEcCtD
Eszopiclone—GABRA2—Ion channel transport—CLCN4—nephrolithiasis	0.00687	0.0232	CbGpPWpGaD
Eszopiclone—GABRA2—Ion channel transport—CLCN5—nephrolithiasis	0.00687	0.0232	CbGpPWpGaD
Eszopiclone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00681	0.00968	CcSEcCtD
Eszopiclone—GABRG2—Ion channel transport—CLCN5—nephrolithiasis	0.0067	0.0226	CbGpPWpGaD
Eszopiclone—GABRG2—Ion channel transport—CLCN4—nephrolithiasis	0.0067	0.0226	CbGpPWpGaD
Eszopiclone—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00649	0.00923	CcSEcCtD
Eszopiclone—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00648	0.00921	CcSEcCtD
Eszopiclone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00645	0.00916	CcSEcCtD
Eszopiclone—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00914	CcSEcCtD
Eszopiclone—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00638	0.00907	CcSEcCtD
Eszopiclone—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00612	0.00871	CcSEcCtD
Eszopiclone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00604	0.00859	CcSEcCtD
Eszopiclone—GABRA1—Ion channel transport—CLCN5—nephrolithiasis	0.00585	0.0197	CbGpPWpGaD
Eszopiclone—GABRA1—Ion channel transport—CLCN4—nephrolithiasis	0.00585	0.0197	CbGpPWpGaD
Eszopiclone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00572	0.00814	CcSEcCtD
Eszopiclone—Tension—Hydrochlorothiazide—nephrolithiasis	0.00553	0.00787	CcSEcCtD
Eszopiclone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00552	0.00785	CcSEcCtD
Eszopiclone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00548	0.00779	CcSEcCtD
Eszopiclone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00545	0.00775	CcSEcCtD
Eszopiclone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00542	0.00771	CcSEcCtD
Eszopiclone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00755	CcSEcCtD
Eszopiclone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00751	CcSEcCtD
Eszopiclone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00744	CcSEcCtD
Eszopiclone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00741	CcSEcCtD
Eszopiclone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00737	CcSEcCtD
Eszopiclone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00515	0.00732	CcSEcCtD
Eszopiclone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00509	0.00723	CcSEcCtD
Eszopiclone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00507	0.0072	CcSEcCtD
Eszopiclone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00708	CcSEcCtD
Eszopiclone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00682	CcSEcCtD
Eszopiclone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00682	CcSEcCtD
Eszopiclone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00478	0.0068	CcSEcCtD
Eszopiclone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00474	0.00674	CcSEcCtD
Eszopiclone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00667	CcSEcCtD
Eszopiclone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00464	0.0066	CcSEcCtD
Eszopiclone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00654	CcSEcCtD
Eszopiclone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00639	CcSEcCtD
Eszopiclone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00445	0.00632	CcSEcCtD
Eszopiclone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00624	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00596	CcSEcCtD
Eszopiclone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00592	CcSEcCtD
Eszopiclone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00587	CcSEcCtD
Eszopiclone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0041	0.00583	CcSEcCtD
Eszopiclone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00582	CcSEcCtD
Eszopiclone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00405	0.00576	CcSEcCtD
Eszopiclone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.004	0.00569	CcSEcCtD
Eszopiclone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00397	0.00564	CcSEcCtD
Eszopiclone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00559	CcSEcCtD
Eszopiclone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00559	CcSEcCtD
Eszopiclone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00539	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00535	CcSEcCtD
Eszopiclone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00366	0.0052	CcSEcCtD
Eszopiclone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00517	CcSEcCtD
Eszopiclone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00517	CcSEcCtD
Eszopiclone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00482	CcSEcCtD
Eszopiclone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00469	CcSEcCtD
Eszopiclone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00463	CcSEcCtD
Eszopiclone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00448	CcSEcCtD
Eszopiclone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00433	CcSEcCtD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00303	0.0102	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00303	0.0102	CbGpPWpGaD
Eszopiclone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00293	0.00416	CcSEcCtD
Eszopiclone—Rash—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00412	CcSEcCtD
Eszopiclone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00412	CcSEcCtD
Eszopiclone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00288	0.0041	CcSEcCtD
Eszopiclone—PTGS1—Biological oxidations—SLC26A1—nephrolithiasis	0.00286	0.00963	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00279	0.0094	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00279	0.0094	CbGpPWpGaD
Eszopiclone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00389	CcSEcCtD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0027	0.0091	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00255	0.0086	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00255	0.0086	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00248	0.00838	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00248	0.00835	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00248	0.00835	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00247	0.00833	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00247	0.00833	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00243	0.0082	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00243	0.0082	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00239	0.00806	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00239	0.00806	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00233	0.00786	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00233	0.00786	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00227	0.00766	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00227	0.00766	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00227	0.00766	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00221	0.00744	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00217	0.00731	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00213	0.00718	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00208	0.00701	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00208	0.00701	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00208	0.00701	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00204	0.00687	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00204	0.00687	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00202	0.00681	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00202	0.00681	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00198	0.00668	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00198	0.00668	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00195	0.00657	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00195	0.00657	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0019	0.00641	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0019	0.00641	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00187	0.00631	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00187	0.00631	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.00185	0.00622	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00182	0.00612	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00174	0.00587	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00174	0.00587	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00172	0.00581	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00172	0.00581	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00166	0.0056	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00166	0.0056	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0016	0.0054	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0016	0.0054	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00157	0.00531	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00157	0.00531	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00155	0.00523	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00155	0.00523	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00153	0.00516	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00153	0.00516	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0015	0.00507	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0015	0.00507	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.0015	0.00506	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00148	0.00498	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00148	0.00498	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00146	0.00494	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00146	0.00494	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00144	0.00486	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00144	0.00486	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00143	0.00481	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00143	0.00481	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00142	0.0048	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00142	0.0048	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0014	0.00471	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0014	0.00471	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00137	0.00463	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00137	0.00463	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00134	0.00452	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00134	0.00452	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0013	0.0044	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0013	0.0044	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00127	0.00427	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00127	0.00427	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00126	0.00425	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00126	0.00425	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00124	0.0042	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00124	0.0042	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00124	0.00418	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00122	0.00413	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00122	0.00413	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00119	0.00402	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00119	0.00402	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00117	0.00395	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00117	0.00395	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00114	0.00385	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00104	0.00352	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00104	0.00352	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00104	0.00352	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00101	0.00342	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000995	0.00336	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00099	0.00334	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000978	0.0033	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000954	0.00322	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000834	0.00281	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000645	0.00217	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AGXT—nephrolithiasis	0.000575	0.00194	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—APRT—nephrolithiasis	0.000489	0.00165	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.000489	0.00165	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000416	0.0014	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000371	0.00125	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AQP1—nephrolithiasis	0.000348	0.00117	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000339	0.00114	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000316	0.00106	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000316	0.00106	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.000315	0.00106	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000302	0.00102	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000257	0.000866	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000257	0.000866	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000225	0.000758	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000224	0.000754	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000203	0.000686	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000199	0.000672	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000183	0.000617	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000169	0.000571	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000169	0.000571	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000166	0.000558	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000121	0.000407	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000109	0.000368	CbGpPWpGaD
